Skip to main content

Published locations for FDA panel endorses teplizumab for delaying type 1 diabetes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel endorses teplizumab for delaying type 1 diabetes

User login

  • Reset your password
  • /content/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /familypracticenews/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /internalmedicinenews/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /pediatricnews/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /clinicalendocrinologynews/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1
  • /jcomjournal/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /pediatrics/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /endocrinology/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /internalmedicine/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /familymedicine/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes
  • /type-2-diabetes-icymi/article/240803/diabetes/fda-panel-endorses-teplizumab-delaying-type-1-diabetes